ArticleDiabetology international2021

Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).

Hiroshi Maegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.